Pavel Raifeld is the Chief Executive Officer of Innoviva, Inc., a diversified holding company with a portfolio of royalties and other healthcare assets. Prior to his appointment as CEO in 2020, Raifeld served as the company's Chief Operating Officer and Senior Vice President of Operations. His extensive background in the pharmaceutical industry spans over two decades, during which he has held various leadership positions in operations, business development, and strategy. Before joining Innoviva, Raifeld worked at Theravance Biopharma, where he played a key role in the development and commercialization of respiratory therapies. His expertise in driving operational excellence and strategic growth has been instrumental in Innoviva's success. Under his leadership, the company has focused on expanding its royalty portfolio and investing in promising healthcare ventures. Raifeld's vision for Innoviva is to continue building a diversified and sustainable business that delivers long-term value to shareholders. As CEO, Pavel Raifeld is responsible for overseeing Innoviva's overall strategy and operations. He works closely with the company's board of directors and executive team to identify new opportunities for growth and to ensure the effective management of the company's assets. Raifeld's leadership style emphasizes collaboration, innovation, and a commitment to excellence. His contributions to the company have been recognized by industry peers, and he continues to be a driving force behind Innoviva's mission to improve patient outcomes and create value for stakeholders.